Hospital Transplant Programs UAE 2026: Costs, Waiting Lists, and Outcomes

The United Arab Emirates has rapidly emerged as a premier destination for organ transplantation in the Middle East, offering world-class medical facilities, internationally benchmarked success rates, and a robust national framework for organ donation. For patients suffering from end-stage organ failure, understanding the landscape of hospital transplant programs in the UAE in 2026—including associated costs, waiting list dynamics, and clinical outcomes—is essential for making informed healthcare decisions.

This comprehensive guide explores the current state of transplant medicine across the Emirates, detailing the accredited centers, financial considerations, regulatory framework, and the remarkable progress achieved under the Hayat programme.

The Hayat Programme: A National Framework for Organ Donation and Transplantation

At the heart of the UAE’s transplant ecosystem lies the National Programme for Donation and Transplantation of Human Organs and Tissues, known as the Hayat programme. Launched in 2017, this initiative has fundamentally transformed the country’s approach to organ donation and transplantation, establishing a coordinated, ethically grounded system that aligns with international best practices.

By June 2026, the Hayat programme had facilitated more than 1,780 organ transplants from 549 deceased donors, saving over 1,500 lives since its inception. The programme’s success is reflected in the UAE’s deceased donor rate of 13.95 per million population—the highest among Gulf Cooperation Council countries. This achievement represents a significant shift in a region where deceased organ donation was historically limited by cultural and religious considerations.

The programme operates through nine accredited transplant centers distributed across Abu Dhabi, Dubai, and Sharjah, each specializing in different types of organ transplantation. The Ministry of Health and Prevention oversees the national framework, ensuring equitable organ allocation based on medical urgency, transparency in waiting list management, and protection of both donor and recipient rights.

Accredited Transplant Centers in the UAE

The UAE’s transplant infrastructure is anchored by nine accredited centers, each offering distinct expertise and specialized services. Understanding which facility provides specific transplant procedures is crucial for patients navigating the system.

In Abu Dhabi, Cleveland Clinic Abu Dhabi stands as the nation’s premier multi-organ transplant center. Designated as a Centre of Excellence by the Department of Health – Abu Dhabi, it performs heart, lung, liver, kidney, and pancreas transplants. The facility operates the UAE’s only heart and lung transplant programme and houses a dedicated transplant intensive care unit. Cleveland Clinic Abu Dhabi has achieved notable milestones, including performing the nation’s first robotic lung transplant and the first combined heart and double-lung transplant, placing it among only five centers worldwide to accomplish the robotic lung procedure.

SEHA Sheikh Khalifa Medical City provides liver and kidney transplants for both adult and pediatric patients. Burjeel Medical City offers kidney and liver transplant services, while Sheikh Shakhbout Medical City also contributes specialized transplant expertise to Abu Dhabi’s integrated ecosystem.

Dubai’s transplant landscape includes Dubai Hospital, which performs adult kidney transplants, and Al Jalila Children’s Hospital, specializing in pediatric kidney transplants. Mediclinic Dubai provides adult kidney transplant services, while King’s College Hospital London – Dubai offers liver transplants for adults and children, along with living-donor kidney transplants.

In Sharjah, Al Qassimi Hospital performs adult kidney transplants, and Medcare Hospital provides living-donor kidney transplant procedures. This geographic distribution ensures that patients across the Emirates can access transplant services without necessarily traveling to Abu Dhabi or Dubai.

Understanding Transplant Costs in the UAE

For patients considering transplantation in the UAE, financial planning is a critical component of the decision-making process. While the UAE offers world-class medical care, the costs associated with organ transplantation reflect the sophisticated infrastructure, highly trained medical personnel, and advanced technology involved in these complex procedures.

Based on verified data from patient inquiries and official clinic quotations for 2025-2026, kidney transplantation in the UAE starts from approximately $68,000. This represents the most commonly performed transplant procedure in the country, with 924 kidney transplants completed under the Hayat programme as of mid-2026.

Liver transplantation, a more complex procedure requiring extensive surgical expertise and postoperative care, starts from approximately $115,000 in the UAE. The country has performed 502 liver transplants through the Hayat programme, with King’s College Hospital London – Dubai and several Abu Dhabi facilities offering this service.

Heart transplantation, available exclusively at Cleveland Clinic Abu Dhabi, starts from approximately $215,000. Lung transplantation, also performed at Cleveland Clinic Abu Dhabi, begins at approximately $185,000. Combined heart-lung transplantation, the most complex procedure in the transplant spectrum, starts from approximately $385,000.

Corneal transplantation, a tissue transplant procedure that restores vision, starts from approximately $12,500 in the UAE. The Hayat programme has announced plans to expand tissue donation to include corneas, bones, skin, and heart valves, which may increase accessibility to these procedures.

It is important to note that these figures represent starting costs and actual expenses may vary based on individual patient factors, including the complexity of the case, length of hospital stay, postoperative complications, and the cost of immunosuppressive medications required for lifelong management. Patients should consult directly with their chosen transplant center for detailed cost estimates and to explore insurance coverage options.

Waiting Lists and Organ Allocation in the UAE

The demand for organ transplants in the UAE significantly exceeds supply, a challenge shared by transplant programs worldwide. As of 2026, more than 4,000 patients in the UAE are living with chronic kidney failure and awaiting transplantation. This figure underscores the critical need for expanded donation pathways and increased public participation in the Hayat programme.

The waiting list for deceased donor organs is managed through a centralized system that prioritizes patients based on medical urgency, compatibility, and time on the waiting list. Patients with a living donor—typically a relative up to the fourth degree, a spouse married for at least two years, or relatives of either spouse up to the fourth degree—can bypass the deceased donor waiting list entirely, provided the donor meets medical and legal requirements.

As of 2026, the Hayat programme has registered more than 39,000 individuals who have pledged to donate their organs after death. While this represents significant progress in building a national donor registry, the number of actual deceased donors remains limited at 549 as of mid-2026. The Ministry of Health and Prevention has identified expanding donation after circulatory death (DCD) and establishing dedicated hospital-based organ donation units as strategic priorities to increase the donor pool and reduce waiting times.

Regional cooperation plays a supplementary role in addressing organ shortages. More than 550 organs have been exchanged between the UAE, Saudi Arabia, and Kuwait under bilateral agreements that facilitate training, expertise-sharing, and urgent organ transfers for complex cases.

Clinical Outcomes and Success Rates

The UAE’s transplant centers have achieved clinical outcomes that match or exceed international benchmarks, providing reassurance to patients considering transplantation in the country. These results reflect the expertise of multidisciplinary transplant teams, advanced surgical techniques, and comprehensive postoperative care protocols.

Kidney transplantation, the most frequently performed procedure, has achieved a one-year survival rate of 96.5%, with transplanted kidneys maintaining 99% functional efficiency. These outcomes are comparable to leading transplant centers in North America and Europe, demonstrating the UAE’s capacity to deliver high-quality kidney transplant care.

Lung transplantation has recorded a 91.4% survival rate, with all transplanted lungs maintaining full function. This is particularly noteworthy given the complexity of lung transplantation and the limited number of centers worldwide that offer this service.

Heart transplant patients have achieved a 95% survival rate in the first 30 days after surgery, with transplanted hearts retaining 89.5% functional efficiency. The UAE’s heart transplant programme, centered at Cleveland Clinic Abu Dhabi, has established itself as a regional leader in cardiac transplantation.

Liver transplantation has achieved a 93% survival rate, with transplanted livers retaining 92.3% function. Both adult and pediatric liver transplant services are available, with King’s College Hospital London – Dubai and Sheikh Khalifa Medical City among the facilities offering this procedure.

The UAE has also demonstrated leadership in surgical innovation, with Cleveland Clinic Abu Dhabi performing the nation’s first robotic lung transplant and becoming one of only five centers globally to achieve this milestone. Robotic surgery offers greater precision, smaller incisions, and reduced blood loss, potentially leading to faster recovery and improved patient outcomes.

Legal Framework and Ethical Standards

The UAE’s transplant programme operates within a comprehensive legal framework that ensures ethical practice, protects donor and recipient rights, and aligns with international standards. Federal Decree-Law No. 25 of 2023 and its executive regulations govern organ donation and transplantation, establishing rules for fair organ allocation based on medical need and permitting donation between relatives up to the fourth degree, spouses, and their relatives.

Under the law, living donors must be legally competent and donate voluntarily without any financial compensation. Donation is restricted to relatives up to the fourth degree, couples married for at least two years, and relatives of either spouse up to the fourth degree. Exchange transplantation—where a donor-recipient pair exchanges organs with another pair to overcome incompatibility—is also permitted.

For deceased donation, the law requires that death be proven by a committee of three specialized physicians, including one neurologist. Individuals can register their desire to donate through their Emirates ID or other official documents. If the deceased did not express their wishes during life, consent may be obtained from a relative according to a defined order of priority.

The legal framework strictly prohibits any form of commercial trade in human organs. Ministerial Decision No. 26 of 2026 established controls for publicity, advertising, and promotion related to organ donation, requiring that all promotional content emphasizes that donation is altruistic and without financial compensation.

In a significant legislative development, Federal Decree-Law No. 15 of 2025, effective from January 2026, expanded the regulatory scope to include non-human organs and tissues. This amendment creates a framework for animal organ transplantation (xenotransplantation) and manufactured organs produced through 3D bioprinting and tissue engineering, positioning the UAE at the forefront of emerging transplant technologies.

The Future of Transplantation in the UAE

The UAE’s transplant programme is poised for continued expansion, with the Ministry of Health and Prevention announcing plans to introduce face, hand, arm, uterus, and intestine transplants in the next phase of the Hayat programme. These vascularized composite tissue transplants represent the most complex procedures in transplant medicine, requiring extensive multidisciplinary coordination and specialized surgical expertise.

Tissue donation will also expand to include corneas, bones, skin, and heart valves, increasing the availability of life-changing and life-enhancing transplants for patients with conditions affecting these tissues.

The planned establishment of dedicated organ donation units within hospitals represents a strategic initiative to identify potential donors earlier, support donor families through the process, and increase the number of organs available for transplantation. These units will be staffed by trained doctors and nurses specializing in donor identification and coordination.

Advancements in artificial intelligence and organ preservation technology are expected to further enhance the UAE’s transplant capabilities. Dr. Bashir Sankari, Director of the Transplant Programme at Cleveland Clinic Abu Dhabi, has noted that continued advances in these areas will improve organ availability and donor-recipient matching, potentially reducing waiting times and improving outcomes.

Conclusion

The UAE has established itself as a regional leader in organ transplantation, offering accredited centers, internationally benchmarked outcomes, and a robust legal and ethical framework. For patients with end-stage organ failure, the Emirates provide access to kidney, liver, heart, lung, and pancreas transplantation at costs ranging from approximately $68,000 for kidney transplants to $385,000 for combined heart-lung procedures. While waiting lists for deceased donor organs remain challenging, living donor transplantation offers a pathway to timely treatment for eligible patients with compatible relatives. With plans to expand into composite tissue transplantation and emerging technologies, the UAE’s transplant programme is positioned for continued growth and innovation, offering hope to thousands of patients awaiting life-saving treatment.